Lp-PLA2 mass or activity were found to predict CV events also in patients with coronary artery disease (CAD) [24], [25], including survivors of myocardial infarction (MI) [26], and acute coronary syndromes (ACS) [27]. This evidence concerns the gene PLA2G7 and coronary artery disorder.